CTRI/2012/02/002434已完成4 期
To assess the Efficacy, Quality of life and Safety of Image Blanc as a Complexion Lightener / Spot Lightener for the face and neck.
Glenmark Pharmaceuticals Ltd0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •Subjects with hyper pigmentation/dark spots of the face and neck.
- •Age group: 30 years and above
- •Willing to restrain from prolonged exposure to the sun for the length of the study
- •Available for the entire duration of the study
排除标准
- •Hypersensitivity to any ingredients
- •Pregnant and lactating women.
- •Subjects who are already applying anti-aging, skin lightening or AHA (Alpha hydroxy acids) based or retinol based cosmetics or have applied any of these in the last 3 months.
- •Subjects with dermatological disorder of face that may interfere with study evaluation.
- •Subjects who have undergone any surgical treatment of the face.
研究者
相似试验
已完成
4 期
To assess the efficacy of anti-wrinkle products.CTRI/2012/04/002551Glenmark Pharmaceuticals Limited100
未知
不适用
STUDY OF THE EFFICACY, SAFETY AND QUALITY OF LIFE AFTER TOOKAD® SOLUBLE VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR MINIMALLY INVASIVE TREATMENT OF LOCALIZED PROSTATE CANCER.PER-046-13Steba biotech S.A,18
招募中
2 期
Comparison of the efficacy of botulinum toxin and triamcinolone in patients with hypertrophic scars treated with PDL laserHypertrophic scarIRCT20220121053776N1Iran University of Medical Sciences12
进行中（未招募）
1 期
A study of efficacy, safety, and quality of life (QOL) in patients with chronic idiopathic urticaria dosed with Aerius tablets (5 mg, 10 mg or 20 mg once daily). - ACCEchronic idiopathic urticariaMedDRA version: 6.1 Level: PT Classification code 10021247EUCTR2006-001449-33-ITSCHERING-PLOUGH600
招募中
不适用
To evaluate the efficacy, safety and QOL(quality of life) of blonanserin monotherapy in schizophrenia patientsMental and behavioral disordersKCT0001105Koera University Guro Hospital100